Physician

Family Medicine

Dr. George W. Koss, DO

George Koss works in the field of Family Medicine. George W. Koss, DO is a published doctor. He has 38 publications published. The most current publication "[Aviation fuels and aircraft emissions. A risk characterization for airport neighbors using Hamburg Airport as an example]."

Publications

[Acute pancreatitis. The "cut-off'' sign].
[Uncertainty analysis of quantitative risk assessment in temporally variable exposures: model observations based on biological and epidemiological risk models].
[Aviation fuels and aircraft emissions. A risk characterization for airport neighbors using Hamburg Airport as an example].
[Evaluation and requirements of natural room ventilation].
2,2'',3'',4,4''5,5''-Hepatachlorobiphenyl (PCB 180)--on its toxicokinetics, biotransformation and porphyrinogenic action in female rats.
CCK-8 and gastrin plasma levels in cholecystectomized and colorectal cancer patients.
2,2'',4,4'',5,5''-hexabromobiphenyl: its toxicokinetics, biotransformation and porphyrinogenic action in rats.
Conversion products of hexachlorobenzene and their role in the disturbance of the porphyrin pathway in rats.
Uroporphyrinogen decarboxylase deficiency in experimental chronic hepatic porphyria.
Effects of dietary antioxidants on the biotransformation and porphyrinogenic action of hexachlorobenzene in two strains of rats.
Biotransformation and porphyringogenic action of hexachlorobenzene and its metabolites in a primary liver cell culture.
Metabolic fate of hexabromobenzene in rats.
Enteral absorption and biotransformation of the food additive octyl gallate in the rat.
Studies on the toxicology of hexachlorobenzene. V. Different phases of porphyria during and after treatment.
Hexachlorobenzene and 2, 4, 5, 2; 4; 5''-hexachlorobiphenyl - a comparison of their distribution, biotransformation and porphyrinogenic action in female rats.
Elimination of porphyrins and their precursors in rats pretreated with hexabromobenzene.
Screening for the ability of hexachlorobenzene metabolites to decrease rat liver porphyrinogen carboxy-lyase.
Time-course and extent of disturbance of the hepatic porphyrin pathway in hexachlorobenzene-exposed female rats.
Ability of several hexachlorobenzene metabolites to decrease rat-liver porphyrinogen carboxy-lyase and to produce porphyrin accumulation in chick-embryo liver.
Excretion of metabolites of hexachlorobenzene in the rat and in man.
Inhibitory effect of tetrachloro-p-hydroquinone and other metabolites of hexachlorobenzene on hepatic uroporphyrinogen decarboxylase activity with reference to the rol...
Interactions of heterocyclic Maillard products with the hepatic microsomal monooxygenase system.
[The value of 2 distinct prognosis scores in patients with peritonitis. The Mannheim Peritonitis Index versus the Apache II score].
Human risk assessment of carcinogens from an administrative perspective.
[Health effects of ozone as component of summer smog].
[Organic-chemical air pollutants indoors--aspects of environmental toxicologic evaluation].
Disseminated histoplasmosis in AIDS patients in Maryland.
The hepatic glutathione content and glutathione S-transferase activity in the pike (Esox lucius L.) and rat.
Residues of hexachlorobenzene in wild mammals of Germany.
Studies on the toxicology of hexachlorobenzene. I. Pharmacokinetics.
Proceedings: Behaviour and biotransformation of 14C-hexachlorobenzene in rats.
Hexachlorobenzene porphyria in rats as a model for human chronic hepatic porphyrias.
Studies on the toxicology of hexachlorobenzene. II. Identification and determination of metabolites.
[Hepatocyte changes following long term poisoning with hexachlorobenzol].
Studies on the toxicology of hexachlorobenzene. III. Observations in a long-term experiment.
Studies on the toxicology of hexachlorobenzene. IV. Sulphur-containing metabolites.
Rat liver alterations after chronic treatment with hexachlorobenzene.

Schools

Univ Of Ca

Doctors Specialties

Family Medicine

Accepted Insurances

Medicare MCR

Helpful Reviews

Give Anonymous Review

Similar Doctors

	Dr. Debra M. Kraft, MD This Doctor is OpenDoctor Recommended.
	Dr. Kamran A. Khan, MD This Doctor is OpenDoctor Recommended.
	Dr. Erin J. Longley, MD This Doctor is OpenDoctor Recommended.
	Dr. Tina M. Hawley, MD
	Dr. Sabrina T. Hart, MD This Doctor is OpenDoctor Recommended.
	Dr. Laurence E. Fox, MD This Doctor is OpenDoctor Recommended.
	Dr. Zohreh E. Safai, MD
	Dr. Deardra E. Rivera, MD This Doctor is OpenDoctor Recommended.
	Barbara A. Staab, ARNP This Doctor is OpenDoctor Recommended.